Monoclonal Antibody Responses Elicited by COVID-19 Vaccination and Natural Infection Studied in New Research

Strategic Insights -

New research has shed light on the mechanisms underlying the development of monoclonal antibody responses elicited by COVID-19 vaccination and natural infection. Investigators from the Southern University of Science and Technology (SUSTech) have investigated the monoclonal antibody responses elicited by wild-type SARS-CoV-2 inactivated vaccination compared to those elicited by natural infection and mRNA vaccination. The study found that antibodies encoded by biased germline genes were shared between SARS-CoV-2 vaccinated and naturally infected individuals, and that a class of IGHV4-59 antibodies characterized by rapid response and neutralizing activity was elicited by 3 doses of inactivated vaccine.

Key Takeaways:

  • The study investigated the monoclonal antibody responses elicited by wild-type SARS-CoV-2 inactivated vaccination compared to those elicited by natural infection and mRNA vaccination.
  • Antibodies encoded by biased germline genes were shared between SARS-CoV-2 vaccinated and naturally infected individuals.
  • A class of IGHV4-59 antibodies characterized by rapid response and neutralizing activity was elicited by 3 doses of inactivated vaccine.
  • Members of this lineage exhibited similar sensitivity against wild-type SARS-CoV-2, but different neutralizing activities against SARS-CoV-2 variants, including Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4/5, and BA.2.75.
  • Two substitutions, N60K in HFR3 and S56G in HCDR2, were identified as contributing to opposite neutralization changes of IGHV4-59-lineage antibodies against these Omicron subvariants.
  • The results demonstrate the importance of somatic hypermutation in the evolution of prototypical antigen-elicited antibodies in terms of their neutralization breadth and potency against SARS-CoV-2 Omicron variants.

Statistics:

  • The study analyzed 35 shared clonotypes between SARS-CoV-2 vaccinated and naturally infected individuals.
  • Among the 35 shared clonotypes, 3 doses of inactivated vaccine elicited a class of IGHV4-59 antibodies characterized by rapid response and neutralizing activity.
  • 2 substitutions, N60K in HFR3 and S56G in HCDR2, were identified as contributing to opposite neutralization changes of IGHV4-59-lineage antibodies against Omicron subvariants.
  • The study demonstrated that the importance of somatic hypermutation in the evolution of prototypical antigen-elicited antibodies in terms of their neutralization breadth and potency against SARS-CoV-2 Omicron variants.

Sources:

  • NewsRx. Findings from Southern University of Science and Technology (SUSTech) Update Knowledge of COVID-19 (Rapid Clonal Expansion and Somatic Hypermutation Contribute To the Fate of Sars-cov-2 Broadly Neutralizing Antibodies). Genomics & Genetics Weekly. May 23, 2025; p 74.
  • The Journal of Immunology, 2025;214(2):278-289.